This report provides a comprehensive analysis of the global Photodynamic Therapy Drugs (PTD) market, exploring the industry's growth trajectory through 2032. It examines key photosensitizing agents, such as Aminolevulinic Acid and Hemoporfin, and their applications in treating various cancers and skin lesions. By evaluating regional dynamics across the Americas, APAC, and Europe, the study highlights emerging opportunities and competitive strategies of major players like DUSA Pharmaceuticals and Soligenix to understand the evolving market landscape.

Executive Overview

Market Definition

Photodynamic therapy drugs (PTD) are photosensitizing agents used in photodynamic therapy, a non-invasive medical treatment that involves the administration of light-sensitive drugs followed by exposure to specific wavelengths of light to target and destroy abnormal cells, such as cancer cells or skin lesions.

Global Market Outlook

The global Photodynamic Therapy Drugs (PTD) market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate.

Regional Market Outlook

• United States: The market for Photodynamic Therapy Drugs (PTD) in the United States is estimated to increase from 2025 through 2032, growing at a consistent compound annual growth rate.
• China: The market for Photodynamic Therapy Drugs (PTD) in China is estimated to increase from 2025 through 2032, growing at a consistent compound annual growth rate.
• Europe: The market for Photodynamic Therapy Drugs (PTD) in Europe is estimated to increase from 2025 through 2032, growing at a consistent compound annual growth rate.

Report Scope and Methodology

Research Objectives

LPI (LP Information)' newest research report, the “Photodynamic Therapy Drugs (PTD) Industry Forecast,” looks at past sales and reviews total world Photodynamic Therapy Drugs (PTD) sales in 2025, providing a comprehensive analysis by region and market sector of projected Photodynamic Therapy Drugs (PTD) sales for 2026 through 2032. With Photodynamic Therapy Drugs (PTD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Photodynamic Therapy Drugs (PTD) industry.

This Insight Report provides a comprehensive analysis of the global Photodynamic Therapy Drugs (PTD) landscape and highlights key trends related to:

• Product segmentation
• Company formation
• Revenue
• Market share
• Latest development
• M&A activity

This report also analyses the strategies of leading global companies with a focus on Photodynamic Therapy Drugs (PTD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Photodynamic Therapy Drugs (PTD) market.

Analytical Framework

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Photodynamic Therapy Drugs (PTD) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Photodynamic Therapy Drugs (PTD).

This report presents a comprehensive overview, market shares, and growth opportunities of Photodynamic Therapy Drugs (PTD) market by product type, application, key players and key regions and countries.

Market Segmentation

By Type

• Aminolevulinic Acid
• Hemoporfin
• Sinoporphyrin Sodium
• Others

By Application

• Pancreatic Cancer
• Esophageal Cancer
• Skin Cancer
• Lung Cancer
• Others

By Region

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Competitive Landscape

Key Market Dynamics

Global key Photodynamic Therapy Drugs (PTD) players include DUSA Pharmaceuticals, Soligenix, ORALIA, Theralase, and Quest Pharmatech. In terms of revenue, the global two largest companies occupied a significant portion of the market share in 2025.

Profiled Companies

The following companies have been profiled based on inputs gathered from primary experts and an analysis of the company's coverage, product portfolio, and market penetration:

• DUSA Pharmaceuticals
• Soligenix
• ORALIA
• Theralase
• Quest Pharmatech
• Biofrontera
• Merck
• QIYUE BIOLOGY
• Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
• Shanghai Guangsheng Pharmaceutical
• APExBIO Technology
• Thermo Fisher

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Photodynamic Therapy Drugs (PTD) Market Size (2021-2032)

    • 2.1.2 Photodynamic Therapy Drugs (PTD) Market Size CAGR by Region (2021 VS 2025 VS 2032)

    • 2.1.3 World Current & Future Analysis for Photodynamic Therapy Drugs (PTD) by Country/Region (2021, 2025 & 2032)

  • 2.2 Photodynamic Therapy Drugs (PTD) Segment by Type

    • 2.2.1 Aminolevulinic Acid

    • 2.2.2 Hemoporfin

    • 2.2.3 Sinoporphyrin Sodium

    • 2.2.4 Others

    • 2.2.5 Photodynamic Therapy Drugs (PTD) Market Size by Type

      • 2.2.5.1 Photodynamic Therapy Drugs (PTD) Market Size CAGR by Type (2021 VS 2025 VS 2032)
      • 2.2.5.2 Global Photodynamic Therapy Drugs (PTD) Market Size Market Share by Type (2021-2026)

  • 2.3 Photodynamic Therapy Drugs (PTD) Segment by Application

    • 2.3.1 Pancreatic Cancer

    • 2.3.2 Esophageal Cancer

    • 2.3.3 Skin Cancer

    • 2.3.4 Lung Cancer

    • 2.3.5 Others

    • 2.3.6 Photodynamic Therapy Drugs (PTD) Market Size by Application

      • 2.3.6.1 Photodynamic Therapy Drugs (PTD) Market Size CAGR by Application (2021 VS 2025 VS 2032)
      • 2.3.6.2 Global Photodynamic Therapy Drugs (PTD) Market Size Market Share by Application (2021-2026)

• 3 Photodynamic Therapy Drugs (PTD) Market Size by Player

  • 3.1 Photodynamic Therapy Drugs (PTD) Market Size Market Share by Player

    • 3.1.1 Global Photodynamic Therapy Drugs (PTD) Revenue by Player (2021-2026)

    • 3.1.2 Global Photodynamic Therapy Drugs (PTD) Revenue Market Share by Player (2021-2026)

  • 3.2 Global Photodynamic Therapy Drugs (PTD) Key Players Head office and Products Offered

  • 3.3 Market Concentration Rate Analysis

    • 3.3.1 Competition Landscape Analysis

    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.4 New Products and Potential Entrants

  • 3.5 Mergers & Acquisitions, Expansion

• 4 Photodynamic Therapy Drugs (PTD) by Region

  • 4.1 Photodynamic Therapy Drugs (PTD) Market Size by Region (2021-2026)

  • 4.2 Global Photodynamic Therapy Drugs (PTD) Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Photodynamic Therapy Drugs (PTD) Market Size Growth (2021-2026)

  • 4.4 APAC Photodynamic Therapy Drugs (PTD) Market Size Growth (2021-2026)

  • 4.5 Europe Photodynamic Therapy Drugs (PTD) Market Size Growth (2021-2026)

  • 4.6 Middle East & Africa Photodynamic Therapy Drugs (PTD) Market Size Growth (2021-2026)

• 5 Americas

  • 5.1 Americas Photodynamic Therapy Drugs (PTD) Market Size by Country (2021-2026)

  • 5.2 Americas Photodynamic Therapy Drugs (PTD) Market Size by Type (2021-2026)

  • 5.3 Americas Photodynamic Therapy Drugs (PTD) Market Size by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Photodynamic Therapy Drugs (PTD) Market Size by Region (2021-2026)

  • 6.2 APAC Photodynamic Therapy Drugs (PTD) Market Size by Type (2021-2026)

  • 6.3 APAC Photodynamic Therapy Drugs (PTD) Market Size by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

• 7 Europe

  • 7.1 Europe Photodynamic Therapy Drugs (PTD) Market Size by Country (2021-2026)

  • 7.2 Europe Photodynamic Therapy Drugs (PTD) Market Size by Type (2021-2026)

  • 7.3 Europe Photodynamic Therapy Drugs (PTD) Market Size by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Photodynamic Therapy Drugs (PTD) by Region (2021-2026)

  • 8.2 Middle East & Africa Photodynamic Therapy Drugs (PTD) Market Size by Type (2021-2026)

  • 8.3 Middle East & Africa Photodynamic Therapy Drugs (PTD) Market Size by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Global Photodynamic Therapy Drugs (PTD) Market Forecast

  • 10.1 Global Photodynamic Therapy Drugs (PTD) Forecast by Region (2027-2032)

    • 10.1.1 Global Photodynamic Therapy Drugs (PTD) Forecast by Region (2027-2032)

    • 10.1.2 Americas Photodynamic Therapy Drugs (PTD) Forecast

    • 10.1.3 APAC Photodynamic Therapy Drugs (PTD) Forecast

    • 10.1.4 Europe Photodynamic Therapy Drugs (PTD) Forecast

    • 10.1.5 Middle East & Africa Photodynamic Therapy Drugs (PTD) Forecast

  • 10.2 Americas Photodynamic Therapy Drugs (PTD) Forecast by Country (2027-2032)

    • 10.2.1 United States Market Photodynamic Therapy Drugs (PTD) Forecast

    • 10.2.2 Canada Market Photodynamic Therapy Drugs (PTD) Forecast

    • 10.2.3 Mexico Market Photodynamic Therapy Drugs (PTD) Forecast

    • 10.2.4 Brazil Market Photodynamic Therapy Drugs (PTD) Forecast

  • 10.3 APAC Photodynamic Therapy Drugs (PTD) Forecast by Region (2027-2032)

    • 10.3.1 China Photodynamic Therapy Drugs (PTD) Market Forecast

    • 10.3.2 Japan Market Photodynamic Therapy Drugs (PTD) Forecast

    • 10.3.3 Korea Market Photodynamic Therapy Drugs (PTD) Forecast

    • 10.3.4 Southeast Asia Market Photodynamic Therapy Drugs (PTD) Forecast

    • 10.3.5 India Market Photodynamic Therapy Drugs (PTD) Forecast

    • 10.3.6 Australia Market Photodynamic Therapy Drugs (PTD) Forecast

  • 10.4 Europe Photodynamic Therapy Drugs (PTD) Forecast by Country (2027-2032)

    • 10.4.1 Germany Market Photodynamic Therapy Drugs (PTD) Forecast

    • 10.4.2 France Market Photodynamic Therapy Drugs (PTD) Forecast

    • 10.4.3 UK Market Photodynamic Therapy Drugs (PTD) Forecast

    • 10.4.4 Italy Market Photodynamic Therapy Drugs (PTD) Forecast

    • 10.4.5 Russia Market Photodynamic Therapy Drugs (PTD) Forecast

  • 10.5 Middle East & Africa Photodynamic Therapy Drugs (PTD) Forecast by Region (2027-2032)

    • 10.5.1 Egypt Market Photodynamic Therapy Drugs (PTD) Forecast

    • 10.5.2 South Africa Market Photodynamic Therapy Drugs (PTD) Forecast

    • 10.5.3 Israel Market Photodynamic Therapy Drugs (PTD) Forecast

    • 10.5.4 Turkey Market Photodynamic Therapy Drugs (PTD) Forecast

  • 10.6 Global Photodynamic Therapy Drugs (PTD) Forecast by Type (2027-2032)

  • 10.7 Global Photodynamic Therapy Drugs (PTD) Forecast by Application (2027-2032)

    • 10.7.1 GCC Countries Market Photodynamic Therapy Drugs (PTD) Forecast

• 11 Key Players Analysis

  • 11.1 DUSA Pharmaceuticals

    • 11.1.1 DUSA Pharmaceuticals Company Information

    • 11.1.2 DUSA Pharmaceuticals Photodynamic Therapy Drugs (PTD) Product Offered

    • 11.1.3 DUSA Pharmaceuticals Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2021-2026)

    • 11.1.4 DUSA Pharmaceuticals Main Business Overview

    • 11.1.5 DUSA Pharmaceuticals Latest Developments

  • 11.2 Soligenix

    • 11.2.1 Soligenix Company Information

    • 11.2.2 Soligenix Photodynamic Therapy Drugs (PTD) Product Offered

    • 11.2.3 Soligenix Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2021-2026)

    • 11.2.4 Soligenix Main Business Overview

    • 11.2.5 Soligenix Latest Developments

  • 11.3 ORALIA

    • 11.3.1 ORALIA Company Information

    • 11.3.2 ORALIA Photodynamic Therapy Drugs (PTD) Product Offered

    • 11.3.3 ORALIA Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2021-2026)

    • 11.3.4 ORALIA Main Business Overview

    • 11.3.5 ORALIA Latest Developments

  • 11.4 Theralase

    • 11.4.1 Theralase Company Information

    • 11.4.2 Theralase Photodynamic Therapy Drugs (PTD) Product Offered

    • 11.4.3 Theralase Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2021-2026)

    • 11.4.4 Theralase Main Business Overview

    • 11.4.5 Theralase Latest Developments

  • 11.5 Quest Pharmatech

    • 11.5.1 Quest Pharmatech Company Information

    • 11.5.2 Quest Pharmatech Photodynamic Therapy Drugs (PTD) Product Offered

    • 11.5.3 Quest Pharmatech Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2021-2026)

    • 11.5.4 Quest Pharmatech Main Business Overview

    • 11.5.5 Quest Pharmatech Latest Developments

  • 11.6 Biofrontera

    • 11.6.1 Biofrontera Company Information

    • 11.6.2 Biofrontera Photodynamic Therapy Drugs (PTD) Product Offered

    • 11.6.3 Biofrontera Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2021-2026)

    • 11.6.4 Biofrontera Main Business Overview

    • 11.6.5 Biofrontera Latest Developments

  • 11.7 Merck

    • 11.7.1 Merck Company Information

    • 11.7.2 Merck Photodynamic Therapy Drugs (PTD) Product Offered

    • 11.7.3 Merck Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2021-2026)

    • 11.7.4 Merck Main Business Overview

    • 11.7.5 Merck Latest Developments

  • 11.8 QIYUE BIOLOGY

    • 11.8.1 QIYUE BIOLOGY Company Information

    • 11.8.2 QIYUE BIOLOGY Photodynamic Therapy Drugs (PTD) Product Offered

    • 11.8.3 QIYUE BIOLOGY Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2021-2026)

    • 11.8.4 QIYUE BIOLOGY Main Business Overview

    • 11.8.5 QIYUE BIOLOGY Latest Developments

  • 11.9 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical

    • 11.9.1 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Company Information

    • 11.9.2 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Photodynamic Therapy Drugs (PTD) Product Offered

    • 11.9.3 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2021-2026)

    • 11.9.4 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Main Business Overview

    • 11.9.5 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Latest Developments

  • 11.10 Shanghai Guangsheng Pharmaceutical

    • 11.10.1 Shanghai Guangsheng Pharmaceutical Company Information

    • 11.10.2 Shanghai Guangsheng Pharmaceutical Photodynamic Therapy Drugs (PTD) Product Offered

    • 11.10.3 Shanghai Guangsheng Pharmaceutical Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2021-2026)

    • 11.10.4 Shanghai Guangsheng Pharmaceutical Main Business Overview

    • 11.10.5 Shanghai Guangsheng Pharmaceutical Latest Developments

  • 11.11 APExBIO Technology

    • 11.11.1 APExBIO Technology Company Information

    • 11.11.2 APExBIO Technology Photodynamic Therapy Drugs (PTD) Product Offered

    • 11.11.3 APExBIO Technology Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2021-2026)

    • 11.11.4 APExBIO Technology Main Business Overview

    • 11.11.5 APExBIO Technology Latest Developments

  • 11.12 Thermo Fisher

    • 11.12.1 Thermo Fisher Company Information

    • 11.12.2 Thermo Fisher Photodynamic Therapy Drugs (PTD) Product Offered

    • 11.12.3 Thermo Fisher Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2021-2026)

    • 11.12.4 Thermo Fisher Main Business Overview

    • 11.12.5 Thermo Fisher Latest Developments

• 12 Research Findings and Conclusion